Brain antibodies in MS-patients — an activity parameter for immunosuppressive therapy?

por Henneberg, A.E., Pfau, J., Hartmann, P., Bittmann, H., Link, D., Wollinsky, K.H.
Publicado 1994

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System

por Abu Hejleh, AP, Huck, K, Jähne, K, Tan, CL, Lanz, TV, Epping, L, Sonner, JK, Meuth, SG, Henneberg, A, Opitz, CA, Herold-Mende, C, Sahm, F, Platten, M, Sahm, K
Publicado 2023